Functional analysis of TPM domain containing Rv2345 of Mycobacterium tuberculosis identifies its phosphatase activity

Protein Expression and Purification
Avni SinhaUrmi Bajpai

Abstract

Mycobacterium tuberculosis (Mtb) is the causal agent of tuberculosis, the second largest infectious disease. With the rise of multi-drug resistant strains of M. tuberculosis, serious challenge lies ahead of us in treating the disease. The availability of complete genome sequence of Mtb has improved the scope for identifying new proteins that would not only further our understanding of biology of the organism but could also serve to discover new drug targets. In this study, Rv2345, a hypothetical membrane protein of M. tuberculosis H37Rv, which is reported to be a putative ortholog of ZipA cell division protein has been assigned function through functional annotation using bioinformatics tools followed by experimental validation. Sequence analysis showed Rv2345 to have a TPM domain at its N-terminal region and predicted it to have phosphatase activity. The TPM domain containing region of Rv2345 was cloned and expressed using pET28a vector in Escherichia coli and purified by Nickel affinity chromatography. The purified TPM domain was tested in vitro and our results confirmed it to have phosphatase activity. The enzyme activity was first checked and optimized with pNPP as substrate, followed by using ATP, which was also found to b...Continue Reading

References

Jan 1, 1997·Annual Review of Biochemistry·J Lutkenhaus, S G Addinall
May 11, 2004·American Journal of Respiratory and Critical Care Medicine·David E Griffith
Jun 28, 2005·Nucleic Acids Research·Johannes SödingAndrei N Lupas
Jun 20, 2007·The Biochemical Journal·Sari SirpiöEva-Mari Aro
Nov 24, 2007·BMC Bioinformatics·Daniel H HusonRegula Rupp
Mar 7, 2008·Microbiology and Molecular Biology Reviews : MMBR·Erik C Hett, Eric J Rubin
Mar 8, 2008·Nature Reviews. Drug Discovery·Rowena L Lock, Elizabeth J Harry
May 15, 2008·BMC Structural Biology·Carolina Perez-Iratxeta, Miguel A Andrade-Navarro
Dec 23, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zarir F UdwadiaCamilla Rodrigues
Dec 27, 2011·Journal of Structural and Functional Genomics·Alexander EletskyThomas Szyperski
Aug 28, 2012·Nature Neuroscience·Thomas BoulinJean-Louis Bessereau
Nov 30, 2013·Nucleic Acids Research·Robert D FinnMarco Punta
May 2, 2014·Frontiers in Microbiology·Catriona Donovan, Marc Bramkamp

❮ Previous
Next ❯

Citations

Nov 5, 2016·Journal of Structural Biology·María L CeruttiMartín Aran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.